Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-30

Clinical Trial Update: A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease. [NA]

View source ↗

Summary

A prospective evaluation of radiofrequency ablation for treating relapsed Graves' disease, with the trial currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Hong Kong | Conditions: Relapsed Graves' Disease, Thyroid; Functional Disturbance | NA | Status: ACTIVE_NOT_RECRUITING